CC
Casdin Capital Portfolio holdings
AUM
$1.1B
1-Year Return
24.98%
This Quarter Return
-10.27%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$1.22B
AUM Growth
-$272M
(-18%)
Cap. Flow
-$1.35M
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
79.8%
Holding
46
New
8
Increased
5
Reduced
10
Closed
2
Top Buys
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
+$10.9M |
| 2 |
MAZE
Maze Therapeutics, Inc. Common Stock
MAZE
|
+$10.4M |
| 3 |
GE HealthCare
GEHC
|
+$8.07M |
| 4 |
Hims & Hers Health
HIMS
|
+$5.91M |
| 5 |
Standard BioTools
LAB
|
+$5.21M |
Top Sells
| 1 |
Illumina
ILMN
|
+$12.3M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$11M |
| 3 |
Exact Sciences
EXAS
|
+$10.6M |
| 4 |
4D Molecular Therapeutics
FDMT
|
+$6.41M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$5.4M |
Sector Composition
| 1 | Healthcare | 99.52% |
| 2 | Consumer Staples | 0.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Agios Pharmaceuticals
AGIO
$2.14B
| $7.33M | 0.6% |
250,000
| – | – |
|
27
Moderna
MRNA
$9.15B
| $6.38M | 0.52% |
225,000
+50,000
| +29% | +$1.42M |
|
|
28
Hims & Hers Health
HIMS
$12.5B
| $5.91M | 0.48% |
+200,000
| New | +$5.91M |
|
29
Tenaya Therapeutics
TNYA
$196M
| $3.84M | 0.31% |
6,732,971
| – | – |
|
30
Verastem
VSTM
$598M
| $3.62M | 0.3% |
+600,000
| New | +$3.62M |
|
|
SEPN
31
Septerna, Inc. Common Stock
SEPN
$637M
| $3.2M | 0.26% |
553,268
| – | – |
|
32
Solid Biosciences
SLDB
$420M
| $2.87M | 0.23% |
+775,000
| New | +$2.87M |
|
33
Absci
ABSI
$381M
| $2.44M | 0.2% |
973,260
| – | – |
|
34
Teladoc Health
TDOC
$1.36B
| $2.39M | 0.2% |
+300,000
| New | +$2.39M |
|
35
Century Therapeutics
IPSC
$43.3M
| $1.53M | 0.12% |
3,212,316
-1,978,190
| -38% | -$942K |
|
36
Dyne Therapeutics
DYN
$1.87B
| $1.05M | 0.09% |
+100,000
| New | +$1.05M |
|
|
CTNM
37
Contineum Therapeutics
CTNM
$347M
| $1.04M | 0.08% |
148,333
-148,333
| -50% | -$1.04M |
|
38
Recursion Pharmaceuticals
RXRX
$2.11B
| $875K | 0.07% |
165,323
| – | – |
|
39
Pacific Biosciences
PACB
$351M
| $854K | 0.07% |
723,767
-312,092
| -30% | -$368K |
|
40
Prime Medicine
PRME
$726M
| $731K | 0.06% |
367,175
| – | – |
|
41
Monte Rosa Therapeutics
GLUE
$297M
| $399K | 0.03% |
86,014
| – | – |
|
42
Ginkgo Bioworks
DNA
$593M
| $208K | 0.02% |
36,493
| – | – |
|
43
Tango Therapeutics
TNGX
$727M
| $171K | 0.01% |
125,000
-1,063,349
| -89% | -$1.46M |
|
|
KRON
44
DELISTED
Kronos Bio
KRON
| $102K | 0.01% |
123,839
| – | – |
|
|
45
4D Molecular Therapeutics
FDMT
$318M
| – | – |
-1,150,000
| Closed | -$6.41M |
|
46
Fortrea Holdings
FTRE
$917M
| – | – |
-275,000
| Closed | -$5.13M |
|